Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Originally published by BBC World News Read the original
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
